Key Themes & Topics

John Bridgeman | CSO, Immunokey, UK
"Thanks for the invite to speak at the event. It was a really enjoyable meeting and a great opportunity to present our work to the community. Identifying key partners for ImmunoKey’s development plan is a critical aspect of getting our therapies to patients; the CGT and Biologics Manufacturing DACH meeting offered us the opportunity to engage with key CDMOs who can help us achieve this goal."

Terry Gray | Field Marketing Manager, Merck
"I had the pleasure of collaborating with the IMAPAC team during the Irish leg of the Biologics World event in February 2026. The organisers were exceptionally receptive and helpful, ensuring a seamless experience throughout the planning, exhibition logistics, partnering sessions, and sponsor visibility. Their proactive approach in connecting us with potential partners significantly enhanced our ROI. We are already exploring future opportunities to work with the IMAPAC team."

WHO
For CPOs, Heads of External Supply, and Procurement Directors looking to optimise their CDMO network and navigate geopolitical risks.

WHAT
The strategic forum for Sino-European partnerships, dedicated to building secure, cost-effective, and trusted outsourcing relationships in a post-Biosecureworld.

WHY
To master the "Speed vs. Trust" equation: accessing Asian capacity to accelerate timelines while maintaining strict European compliance and IP security.

Senior Attendees
Meet a concentrated audience of CPOs, Heads of External Supply, and Procurement Directors navigating the complexities of the global CDMO market.

Expert Speakers
Hear from world-class leaders in geopolitical strategy, supply chain risk management, and legal compliance regarding the Biosecure Act and Sino-European partnerships.

Companies Represented
A strategic gathering representing European big pharma buyers, "China Champion" CDMOs, legal consultancies, and supply chain audit firms.

Networking Hours
Connect with potential partners to discuss contract structures, IP security, and the future of cost-effective, high-quality outsourcing models.




